Biotech exit activity refers to acquisitions, IPOs, or mergers involving biotech firms. It provides liquidity for investors and founders, validates innovative therapies, and fuels sector growth. Large pharmaceutical companies benefit by acquiring promising pipelines, while venture capitalists gain returns, enabling reinvestment into new startups and advancing medical breakthroughs.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends